Stefanie Howaldt

1.9k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Stefanie Howaldt is a scholar working on Genetics, Epidemiology and Hematology. According to data from OpenAlex, Stefanie Howaldt has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Epidemiology and 12 papers in Hematology. Recurrent topics in Stefanie Howaldt's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (11 papers) and Iron Metabolism and Disorders (10 papers). Stefanie Howaldt is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (11 papers) and Iron Metabolism and Disorders (10 papers). Stefanie Howaldt collaborates with scholars based in Germany, United Kingdom and Austria. Stefanie Howaldt's co-authors include Stefan Schreiber, Andreas Raedler, Christoph Gasché, Steven Fishbane, Michael Hedenus, János Szebeni, S Patni, David S. Rampton, Francesco Locatelli and Bernd Bokemeyer and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Stefanie Howaldt

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

2023 170 citations Geert D’Haens, Marla C. Dubinsky et al. New England Journal of Medicine profile →

Peers

Stefanie Howaldt

HEMAT

GENET

EPIDE

SURGE

O Mickisch Germany

V. P. Choudhry India

E Signer Switzerland

B. A. Chapman New Zealand

Ulas D. Bayraktar United States

Manish J. Gandhi United States

Yago González‐Lama Spain

Adam Gassas Canada

Mark Samaan United Kingdom

Stefan Lethagen Sweden

O Mickisch Germany

Stefanie Howaldt

204 ×0.4

HEMAT

333 ×0.9

GENET

114 ×0.3

GENET

244 ×0.9

EPIDE

225 ×1.2

SURGE

Citations per year, relative to Stefanie Howaldt Stefanie Howaldt (= 1×) peers O Mickisch

Countries citing papers authored by Stefanie Howaldt

Since Specialization

Citations

This map shows the geographic impact of Stefanie Howaldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Howaldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Howaldt more than expected).

Fields of papers citing papers by Stefanie Howaldt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Howaldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Howaldt. The network helps show where Stefanie Howaldt may publish in the future.

Co-authorship network of co-authors of Stefanie Howaldt

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Howaldt. A scholar is included among the top collaborators of Stefanie Howaldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Howaldt. Stefanie Howaldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bokemeyer, Bernd, Sandra Plachta‐Danielzik, Stefanie Howaldt, et al.. (2025). Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study. Journal of Crohn s and Colitis. 19(5). 1 indexed citations

Baumgart, Daniel C., Andreas Stallmach, Philip Grunert, et al.. (2024). Induction and maintenance of mucosal healing in Crohn’s disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS). Scientific Reports. 14(1). 20502–20502. 1 indexed citations

D’Haens, Geert, Marla C. Dubinsky, Taku Kobayashi, et al.. (2023). Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine. 388(26). 2444–2455. 170 indexed citations breakdown →

Howaldt, Stefanie, et al.. (2021). P592 Costs savings associated with ferric maltol and the reduced use of intravenous iron based on real world data. Journal of Crohn s and Colitis. 15(Supplement_1). S541–S542. 2 indexed citations

Howaldt, Stefanie, et al.. (2020). P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV iron. Journal of Crohn s and Colitis. 14(Supplement_1). S319–S320. 3 indexed citations

Howaldt, Stefanie, et al.. (2020). P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 14(Supplement_1). S558–S558. 3 indexed citations

Schölmerich, Jürgen, Klaus Fellermann, Frank Seibold, et al.. (2016). A Randomised, Double-blind, Placebo-controlled Trial ofTrichuris suisova in Active Crohn’s disease. Journal of Crohn s and Colitis. 11(4). jjw184–jjw184. 54 indexed citations

Bokemeyer, Bernd, et al.. (2016). Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency. European Journal of Drug Metabolism and Pharmacokinetics. 42(2). 229–238. 12 indexed citations

Gasché, Christoph, Tariq Ahmad, Zsolt Tulassay, et al.. (2015). Ferric Maltol Is Effective in Correcting Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21(3). 579–588. 96 indexed citations

10.

Szebeni, János, Steven Fishbane, Michael Hedenus, et al.. (2015). Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. British Journal of Pharmacology. 172(21). 5025–5036. 110 indexed citations

11.

Rampton, David S., Steven Fishbane, Michael Hedenus, et al.. (2014). Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica. 99(11). 1671–1676. 220 indexed citations

12.

Beigel, Florian, Niels Teich, Stefanie Howaldt, et al.. (2014). Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study. Journal of Crohn s and Colitis. 8(11). 1471–1479. 58 indexed citations

13.

Kulnigg‐Dabsch, Stefanie, Werner Schmid, Stefanie Howaldt, et al.. (2013). Iron Deficiency Generates Secondary Thrombocytosis and Platelet Activation in IBD. Inflammatory Bowel Diseases. 19(8). 1609–1616. 51 indexed citations

14.

Herrlinger, Klaus, Mircea Diculescu, Klaus Fellermann, et al.. (2012). Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study. Journal of Crohn s and Colitis. 7(8). 636–643. 58 indexed citations

15.

Wenger, Sandra, Susanna Nikolaus, Stefanie Howaldt, et al.. (2011). Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease. Journal of Crohn s and Colitis. 6(1). 21–28. 11 indexed citations

16.

Kulnigg‐Dabsch, Stefanie, Werner Schmid, Stefanie Howaldt, et al.. (2011). Iron Replacement Therapy for Secondary Thrombocytosis in Inflammatory Bowel Disease: Results of a Randomized Controlled Study – The ThromboVIT Trial. Gastroenterology. 140(5). S–265. 1 indexed citations

17.

Vermeire, Séverine, Stefanie Howaldt, Daan W. Hommes, et al.. (2010). Compassionate Use of Certolizumab Pegol in Patients with Crohnʼs Disease Who Have Failed Previous TNF Inhibitor Therapies. The American Journal of Gastroenterology. 105. S416–S416. 1 indexed citations

18.

Dietrich, Eva Susanne, et al.. (1999). Cost-Effectiveness of ceftriaxone 1 g vs second-generation cephalosporins in the treatment of pneumonia in general medical wards in Germany. Infection. 27(2). 148–154. 11 indexed citations

19.

Schreiber, Stefan, Stefanie Howaldt, Susanna Nikolaus, et al.. (1996). Recombinant Erythropoietin for the Treatment of Anemia in Inflammatory Bowel Disease. New England Journal of Medicine. 334(10). 619–624. 170 indexed citations

20.

Howaldt, Stefanie, et al.. (1993). Comparative Trial of Remission Prophylaxis in Quiescent Crohn’s Disease with Oral 4-Aminosalicyclic Acid Versus 5-Aminosalicylic Acid Slow Release Tablets. SHILAP Revista de lepidopterología. 7(2). 241–244. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact